Insiders At Moderna Sold US$3.3m In Stock, Alluding To Potential Weakness
5 Things You Need to Know About COVID, Flu and RSV Vaccines This Fall
Stocks Most Loved and Shunned by Hedge and Mutual Funds
Snowflake, JD.com And Temu Parent PDD Are Among Top 8 Large Cap Losers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?
Sector Update: Health Care Stocks Rise in Late Afternoon Trading
$100 Invested In This Stock 5 Years Ago Would Be Worth $500 Today
The FDA Approved a New Covid Vaccine. Should You Get It? -- Update 2 -- WSJ
U.S. to Restart Free COVID Test Program as Cases Spike
Express News | U.S. CDC Says For This Season Peak Hospitalizations For For Flu And Covid Combined Is Forecasted To Be Similar Or Slightly Improved Over Last Season; Covid Continues To Cause More Serious Disease Than Flu
Express News | US Cdc Official Says Covid Continues to Cause More Serious Disease Than Flu -Press Conference
Express News | US Cdc Says for This Season Peak Hospitalizations for for Flu and Covid Combined Is Forecasted to Be Similar or Slightly Improved Over Last Season-Press Conference
Express News | US Hhs Says Has Launched New National Campaign to Educate Audiences at High Risks of Flu, Covid, 19 and Rsv -Press Conference
Express News | US Cdc Says Free at Home, Covid 19 Test Delivery Programs Will Reopen in Late September -Press Conference
Stocks On Sale: TD, NetEase, Moderna, and Intel
Moderna Wins European Commission Approval for Respiratory Syncytial Virus Vaccine
Sector Update: Health Care Stocks Rise Premarket Friday
Piper Sandler Maintains Moderna(MRNA.US) With Buy Rating, Maintains Target Price $157
Express News | Moderna: Moderna Receives European Commission Approval for Rsv Vaccine Mresvia(R)
Moderna's RSV Vaccine Receives EU Approval for Older Adults
Update: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, BioNTech